Table 1 Positive markers found in the analyses using classification and regression trees

1

D1S1665

GATA61A06

1p31.1

Amylase, salivary, Pancreatic (1p21), facilitated glucose transporter (1p31-35), agiopoietin-like 3 (1p31)

2

D2S2952

GATA116B01

2p25.1

Glucokinase regulatory protein (2p23), Alstrom syndrome (2p13), serum levels of leptin (2p21), hexokinase 2 (2p12), eukaryote translation initiation factor 2-α kinase 3 (Wolcott-Rallison syndrome, 2p21)

6

D6S474

GATA31

6q21

IDDM 1 (6q21) IDDM5 (6q24-27), IDDM8 (6q25-27), IDDM15, transient neonatal diabetes mellitus (6q24), pleomorphic adenoma gene-like 1 (6q24-26), phosphodiesterase 1 (6q22-23)

11

D11S1981

GATA48E02

11p15.1

HRAS (11p14.1), INS (11p14.1), MODY1 (11p15.5), phosphodiesterase 3B (11p15), SUR1 (11p15.1), Kir6.2 (11p15.1)

16

D16S3396

ATA55A11

16q12.1

RRAD (16q22)

D16S3253

GATA22F09

16q12.2

D16S2620

GATA67G11

18

D18S542

GATA11A06

18p11.21

19

D19S254

Mfd238

19q13.43

Glycogen synthase 1 (muscle)(19q13.3), ApoCIII (19q13.2), Dystrophia Myotonica 1 (19q13.2-13.3), AKT2 (19q13.1-13.2), TGFβ1 (19q13.1), Glycogen synthase kinase 3A (19q13.1-13.2)